Safety and effectiveness of first line eflornithine for Trypanosoma brucei gambiense sleeping sickness in Sudan: cohort study.
OBJECTIVE: To assess the safety and effectiveness of eflornithine as first line treatment for human African trypanosomiasis.
DESIGN: Cohort study.